Pharmaceuticals by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

TG Therapeutics leads the 61 pharmaceuticals ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
61
First
TG Therapeutics19.0%
Median
5.47%
Combined market value
SAR 19.06T
Countries
10

Market values as of .

Pharmaceuticals by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1TG TherapeuticsTGTX · Health Care19.0%SAR 35.9BSAR 237.29 0.88% up 107% up United States
2Rhythm PharmaceuticalsRYTM · Health Care16.8%SAR 30.3BSAR 437.10 0.07% down 13% up United States
3Dianthus TherapeuticsDNTH · Health Care16.5%SAR 18.2BSAR 323.04 0.99% down 113% up United States
4Protagonist TherapeuticsPTGX · Health Care15.7%SAR 30.5BSAR 466.96 0.14% down 46% up United States
5Praxis Precision MedicinesPRAX · Health Care15.1%SAR 32BSAR 1,144.45 0.01% up 61% up United States
6CytokineticsCYTK · Health Care12.9%SAR 27BSAR 193.72 0.01% down 20% down United States
7Ionis PharmaceuticalsIONS · Health Care12.7%SAR 16.9BSAR 101.50 0.37% up 64% down United States
8Ligand PharmaceuticalsLGND · Health Care12.3%SAR 22.1BSAR 1,105.49 0.31% up 43% up United States
9Spyre TherapeuticsSYRE · Health Care12.2%SAR 33.6BSAR 353.40 0.43% up 286% up United States
10AlkermesALKS · Health Care11.7%SAR 29.2BSAR 173.60 1.83% up 58% up Ireland
11Edgewise TherapeuticsEWTX · Health Care11.6%SAR 16.7BSAR 152.76 3.13% down 88% up United States
12BridgeBio PharmaBBIO · Health Care10.7%SAR 56.4BSAR 289.69 0.56% up 17% up United States
13ErascaERAS · Health Care10.6%SAR 17.3BSAR 49.29 5.40% down 403% up United States
14Cogent BiosciencesCOGT · Health Care10.0%SAR 18.4BSAR 105.91 1.38% up 20% down United States
15Mirum PharmaceuticalsMIRM · Health Care9.99%SAR 22.3BSAR 341.79 0.90% down 31% up United States
16Travere TherapeuticsTVTX · Health Care9.96%SAR 18BSAR 187.17 2.35% down 44% up United States
17Oruka TherapeuticsORKA · Health Care9.53%SAR 24.5BSAR 361.63 0.09% up 241% up United States
18PTC TherapeuticsPTCT · Health Care9.31%SAR 18.9BSAR 225.96 0.20% down 20% down United States
19Madrigal PharmaceuticalsMDGL · Health Care9.20%SAR 36BSAR 1,550.94 2.02% down 24% down United States
20Jazz PharmaceuticalsJAZZ · Health Care9.03%SAR 58.4BSAR 910.22 0.81% up 37% up Ireland
21Corcept TherapeuticsCORT · Health Care8.34%SAR 27.7BSAR 252.83 3.81% down 8% down United States
22Arrowhead PharmaceuticalsARWR · Health Care8.19%SAR 22.8BSAR 161.39 0.08% up 10% up United States
23VeradermicsMANE · Health Care8.03%SAR 19.5BSAR 463.06 1.74% down 233% up United States
24BioMarin PharmaceuticalBMRN · Health Care7.29%SAR 43.4BSAR 223.90 2.02% up 11% up United States
25Definium TherapeuticsDFTX · Health Care7.02%SAR 14.6BSAR 106.90 3.00% down 169% up United States
26Elanco Animal HealthELAN · Health Care6.59%SAR 49.3BSAR 98.54 1.62% up 20% up United States
27InsmedINSM · Health Care6.42%SAR 98.1BSAR 447.23 2.16% down 40% down United States
28Roivant SciencesROIV · Health Care6.28%SAR 104.9BSAR 144.84 0.25% down 90% up United Kingdom
29Axsome TherapeuticsAXSM · Health Care6.20%SAR 26.1BSAR 496.67 2.60% down 7% down United States
30Legend BiotechLEGN · Health Care6.13%SAR 11.7BSAR 60.20 0.37% down 42% down United States
31Kiniksa Pharmaceuticals InternationalKNSA · Health Care5.47%SAR 28.1BSAR 358.22 0.41% up 126% up United Kingdom
32Summit TherapeuticsSMMT · Health Care5.28%SAR 31.6BSAR 39.54 1.22% down 36% down United States
33ABIVAXABVX · Health Care4.70%SAR 27.4BSAR 313.40 1.77% up 27% down France
34Ascendis PharmaASND · Health Care4.57%SAR 66.4BSAR 1,012.88 0.43% down 28% up Denmark
35United TherapeuticsUTHR · Health Care4.31%SAR 91.1BSAR 2,138.16 2.41% down 23% up United States
36ZoetisZTS · Health Care4.12%SAR 127.5BSAR 313.85 0.23% up 29% down United States
37Alnylam PharmaceuticalsALNY · Health Care4.08%SAR 76.9BSAR 574.03 2.21% down 66% down United States
38Belite BioBLTE · Health Care3.40%SAR 24.2BSAR 594.96 0.57% up 31% up United States
39Amneal PharmaceuticalsAMRX · Health Care3.27%SAR 28BSAR 80.46 1.56% up 83% up United States
40ViatrisVTRS · Health Care3.07%SAR 88.5BSAR 77.21 0.66% up 96% up United States
41Dr. Reddy's LaboratoriesRDY · Health Care3.03%SAR 46.7BSAR 56.06 1.05% up 5% up India
42Teva Pharmaceutical IndustriesTEVA · Health Care2.38%SAR 185BSAR 158.52 0.84% down 74% up Israel
43PfizerPFE · Health Care2.36%SAR 601.7BSAR 105.57 1.14% down 14% up United States
44Bristol-Myers SquibbBMY · Health Care2.29%SAR 458.7BSAR 224.42 2.48% down 34% up United States
45Royalty PharmaRPRX · Health Care2.27%SAR 147.4BSAR 256.34 0.50% down 78% up United States
46Regeneron PharmaceuticalsREGN · Health Care2.14%SAR 370.5BSAR 3,581.94 0.30% down 36% up United States
47Vertex PharmaceuticalsVRTX · Health Care1.90%SAR 507BSAR 1,999.66 0.21% down 27% up United States
48GenmabGMAB · Health Care1.57%SAR 118.6BSAR 192.28 1.35% down 70% up Denmark
49BeOne MedicinesONC · Health Care1.40%SAR 172.9BSAR 1,513.55 2.36% down 17% up Switzerland
50Abbott LaboratoriesABT · Health Care1.10%SAR 676.8BSAR 390.78 0.51% down 17% down United States
51Merck & CoMRK · Health Care1.08%SAR 1.29TSAR 524.05 2.55% down 51% up United States
52AbbVieABBV · Health Care0.89%SAR 1.91TSAR 1,078.07 1.85% down 26% up United States
53GrifolsGRFS · Health Care0.88%SAR 21.7BSAR 31.92 1.39% down 1% up Spain
54Novo NordiskNVO · Health Care0.87%SAR 652.9BSAR 148.15 2.96% down 17% down Denmark
55Eli LillyLLY · Health Care0.81%SAR 4.66TSAR 5,225.97 1.58% down 35% up United States
56GSKGSK · Health Care0.81%SAR 367.2BSAR 183.20 0.81% down 6% up United Kingdom
57Johnson & JohnsonJNJ · Health Care0.71%SAR 2.48TSAR 1,031.56 1.32% down 38% up United States
58SanofiSNY · Health Care0.51%SAR 425.9BSAR 177.38 0.50% down 4% down France
59NovartisNVS · Health Care0.24%SAR 1.11TSAR 586.58 1.73% down 25% up Switzerland
60AstraZenecaAZN · Health Care0.20%SAR 1.04TSAR 670.83 1.88% down 2% up United Kingdom
61Takeda PharmaceuticalTAK · Health Care0.10%SAR 256.2BSAR 80.18 1.22% down 54% up Japan

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).

Questions and answers

Which pharmaceuticals rank first by short interest?

TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceuticals ranked by short interest as of the 30 Oct 2026 settlement date.

How many pharmaceuticals are in this ranking?

61 are ranked by short interest.

What are these pharmaceuticals worth together?

The 61 pharmaceuticals ranked by short interest have a combined market value of SAR 19.06T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Pharmaceuticals by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.